|
1
|
Chen M, Borlak J and Tong W: High
lipophilicity and high daily dose of oral medications are
associated with significant risk for drug-induced liver injury.
Hepatology. 58:388–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGill MR and Jaeschke H: Biomarkers of
drug-induced liver injury: Progress and utility in research,
medicine, and regulation. Expert Rev Mol Diagn. 18:797–807. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crescioli G, Lombardi N, Bettiol A,
Marconi E, Risaliti F, Bertoni M, Menniti Ippolito F, Maggini V,
Gallo E, Firenzuoli F, et al: Acute liver injury following
Garcinia cambogia weight-loss supplementation: Case series
and literature review. Intern Emerg Med. 13:857–872. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Allard J, Le Guillou D, Begriche K and
Fromenty B: Drug-induced liver injury in obesity and nonalcoholic
fatty liver disease. Adv Pharmacol. 85:75–107. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dai C, Xiao X, Li D, Tun S, Wang Y, Velkov
T and Tang S: Chloroquine ameliorates carbon tetrachloride-induced
acute liver injury in mice via the concomitant inhibition of
inflammation and induction of apoptosis. Cell Death Dis.
9:11642018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wendon J, Cordoba J, Dhawan A, Larsen FS,
Manns M, Samuel D, Simpson KJ, Yaron I, Bernardi M; European
Association for the Study of the Liver. Electronic address:
easloffice@easloffice.eu, ; et al: EASL Governing Board
representative: EASL Clinical Practical Guidelines on the
management of acute (fulminant) liver failure. J Hepatol.
66:1047–1081. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramos-Tovar E, Hernández-Aquino E,
Casas-Grajales S, Buendia-Montaño LD, Galindo-Gómez S, Camacho J,
Tsutsumi V and Muriel P: Stevia prevents acute and chronic liver
injury induced by carbon tetrachloride by blocking oxidative stress
through Nrf2 upregulation. Oxid Med Cell Longev. 2018:38234262018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schueller F, Roy S, Loosen SH, Alder J,
Koppe C, Schneider AT, Wandrer F, Bantel H, Vucur M, Mi QS, et al:
miR-223 represents a biomarker in acute and chronic liver injury.
Clin Sci (Lond). 131:1971–1987. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu LM, Tu WJ, Zhu T, Wang XT, Tan ZL,
Zhong H, Gao DY and Liang DY: IRF3 is an important molecule in the
UII/UT system and mediates immune inflammatory injury in acute
liver failure. Oncotarget. 7:49027–49041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao J, Miao G, Wang T, Li J and Xie L:
Urantide attenuates myocardial damage in atherosclerotic rats by
regulating the MAPK signalling pathway. Life Sci. 262:1185512020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang T, Xie YQ, Miao GX, Cui HP, Liu K, Li
Y, Li Y and Zhao J: Urotensin receptor antagonist urantide improves
atherosclerosis-related kidney injury by inhibiting JAK2/STAT3
signaling pathway in rats. Life Sci. 247:1174212020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ross B, McKendy K and Giaid A: Role of
urotensin II in health and disease. Am J Physiol Regul Integr Comp
Physiol. 298:R1156–R1172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leifeld L, Clemens C, Heller J, Trebicka
J, Sauerbruch T and Spengler U: Expression of urotensin II and its
receptor in human liver cirrhosis and fulminant hepatic failure.
Dig Dis Sci. 55:1458–1464. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haston S, Pozzi S, Carreno G, Manshaei S,
Panousopoulos L, Gonzalez-Meljem JM, Apps JR, Virasami A, Thavaraj
S, Gutteridge A, et al: MAPK pathway control of stem cell
proliferation and differentiation in the embryonic pituitary
provides insights into the pathogenesis of papillary
craniopharyngioma. Development. 144:2141–2152. 2017.PubMed/NCBI
|
|
15
|
Peng Z, Gong X, Yang Y, Huang L, Zhang Q,
Zhang P, Wan R and Zhang B: Hepatoprotective effect of quercetin
against LPS/d-GalN induced acute liver injury in mice by inhibiting
the IKK/NF-κB and MAPK signal pathways. Int Immunopharmacol.
52:281–289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ko IG, Jin JJ, Hwang L, Kim SH, Kim CJ,
Han JH, Lee S, Kim HI, Shin HP and Jeon JW: Polydeoxyribonucleotide
exerts protective effect against CCl4-induced acute
liver injury through inactivation of NF-κB/MAPK signaling pathway
in mice. Int J Mol Sci. 21:78942020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Wei X, Wei X, Sun X, Huang X,
Liang Y, Xu W, Zhu X, Lin X and Lin J:
4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced
acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling
pathways in mice. Int Immunopharmacol. 83:1064452020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao J, Xie LD, Song CJ, Mao XX, Yu HR, Yu
QX, Ren LQ, Shi Y, Xie YQ, Li Y, et al: Urantide improves
atherosclerosis by controlling C-reactive protein, monocyte
chemotactic protein-1 and transforming growth factor-β expression
in rats. Exp Ther Med. 7:1647–1652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu LM, Liang DY, Ye CG, Tu WJ and Zhu T:
The UII/UT system mediates upregulation of proinflammatory
cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated
Kupffer cells. PLoS One. 10:e01213832015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
National Research Council, . Guide for the
Care and Use of Laboratory Animals. 8th Edition. The National
Academies Press; 2011, doi: 10.17226/12910.
|
|
21
|
Sarhadynejad Z, Sharififar F, Pardakhty A,
Nematollahi MH, Sattaie-Mokhtari S and Mandegary A: Pharmacological
safety evaluation of a traditional herbal medicine
‘Zereshk-e-Saghir’ and assessment of its hepatoprotective effects
on carbon tetrachloride induced hepatic damage in rats. J
Ethnopharmacol. 190:387–395. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan J, Jie Z, Hou L, Wanderley JL, Soong
L, Gupta S, Qiu S, Chan T and Sun J: Parenchymal expression of CD40
exacerbates adenovirus-induced hepatitis in mice. Hepatology.
53:1455–1467. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Li X, Luo R, Wang W, Wang T and Tang
H: Detection of KIT genotype in pigs by TaqMan MGB Real-time
quantitative polymerase chain reaction. DNA Cell Biol. 37:457–464.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li YY, Ge QX, Cao J, Zhou YJ, Du YL, Shen
B, Wan YJ and Nie YQ: Association of Fusobacterium nucleatum
infection with colorectal cancer in Chinese patients. World J
Gastroenterol. 22:3227–3233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu Y, Lin Y, Huang X, Wu S, Wei J and Yang
C: Oxaliplatin aggravates hepatic oxidative stress, inflammation
and fibrosis in a non-alcoholic fatty liver disease mouse model.
Int J Mol Med. 43:2398–2408. 2019.PubMed/NCBI
|
|
26
|
Urtasun R, Lopategi A, George J, Leung TM,
Lu Y, Wang X, Ge X, Fiel MI and Nieto N: Osteopontin, an oxidant
stress sensitive cytokine, up-regulates collagen-I via integrin
α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology.
55:594–608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Srungaram P, Rule JA, Yuan HJ, Reimold A,
Dahl B, Sanders C and Lee WM; Acute Liver Failure Study Group, :
Plasma osteopontin in acute liver failure. Cytokine. 73:270–276.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen
W, Li X, Wang L, Wang L, Liu Y, et al: Mortality, morbidity, and
risk factors in China and its provinces, 1990–2017: A systematic
analysis for the Global Burden of Disease Study 2017. Lancet.
394:1145–1158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang W, Jiang L, Ren Y, Shen M and Xie J:
Characterizations and hepatoprotective effect of polysaccharides
from Mesona blumes against tetrachloride-induced acute liver injury
in mice. Int J Biol Macromol. 124:788–795. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munakarmi S, Chand L, Shin HB, Jang KY and
Jeong YJ: Indole-3-carbinol derivative DIM mitigates carbon
tetrachloride-induced acute liver injury in mice by inhibiting
inflammatory response, apoptosis and regulating oxidative stress.
Int J Mol Sci. 21:20482020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang W, Dong Z, Chang X, Zhang C, Rong G,
Gao X, Zeng Z, Wang C, Chen Y, Rong Y, et al: Protective effect of
the total flavonoids from Apocynum venetum L. on carbon
tetrachloride-induced hepatotoxicity in vitro and in vivo. J
Physiol Biochem. 74:301–312. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zira A, Kostidis S, Theocharis S, Sigala
F, Engelsen SB, Andreadou I and Mikros E: 1H NMR-based metabonomics
approach in a rat model of acute liver injury and regeneration
induced by CCl4 administration. Toxicology. 303:115–124.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuang Y, Han X, Xu M, Wang Y, Zhao Y and
Yang Q: Oxaloacetate ameliorates chemical liver injury via
oxidative stress reduction and enhancement of bioenergetic fluxes.
Int J Mol Sci. 19:16262018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Wen PH, Zhang XX, Dai Y and He Q:
Breviscapine ameliorates CCl4-induced liver injury in
mice through inhibiting inflammatory apoptotic response and ROS
generation. Int J Mol Med. 42:755–768. 2018.PubMed/NCBI
|
|
35
|
Wang M, Niu J, Ou L, Deng B, Wang Y and Li
S: Zerumbone protects against carbon tetrachloride
(CCl4)-induced acute liver injury in mice via inhibiting
oxidative stress and the inflammatory response: Involving the
TLR4/NF-κB/COX-2 pathway. Molecules.
24:19642019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu T, Shen M, Liu S, Yu Q, Chen Y and Xie
J: Ameliorative effect of Cyclocarya paliurus
polysaccharides against carbon tetrachloride induced oxidative
stress in liver and kidney of mice. Food Chem Toxicol.
135:1110142020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liang DY, Liu LM, Ye CG, Zhao L, Yu FP,
Gao DY and Wang YY, Yang ZW and Wang YY: Inhibition of UII/UTR
system relieves acute inflammation of liver through preventing
activation of NF-κB pathway in ALF mice. PLoS One. 8:e648952013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu Y, Hu D, Ma S, Zhao X, Wang S, Wei G,
Wang X, Wen A and Wang J: Protective effect of wedelolactone
against CCl4-induced acute liver injury in mice. Int
Immunopharmacol. 34:44–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mo W, Wang C, Li J, Chen K, Xia Y, Li S,
Xu L, Lu X, Wang W and Guo C: Fucosterol protects against
concanavalin A-induced acute liver injury: Focus on P38 MAPK/NF-κB
pathway activity. Gastroenterol Res Pract. 2018:28241392018.
View Article : Google Scholar : PubMed/NCBI
|
